NeoGenomics

About NeoGenomics

NeoGenomics is a leading provider of cancer-focused genetic testing services, dedicated to advancing the field of oncology through innovative diagnostic solutions. Established with the vision of improving patient outcomes, the company offers a comprehensive range of tests that assist in the diagnosis, treatment, and monitoring of cancer.

With a commitment to quality and accuracy, NeoGenomics employs state-of-the-art technology and a team of expert pathologists and scientists. Their extensive test menu includes molecular testing, cytogenetics, and pathology services, catering to the needs of healthcare providers and patients alike.

NeoGenomics operates multiple laboratories across the United States and has expanded its reach internationally, including a growing presence in the UK. The company prides itself on its robust research and development initiatives, which drive the continuous improvement of its testing capabilities.

In addition to its testing services, NeoGenomics provides educational resources and support to healthcare professionals, ensuring they are equipped with the latest information on cancer genomics. The company’s dedication to collaboration with oncologists and researchers fosters an environment of innovation and excellence.

As part of its mission, NeoGenomics aims to make precision medicine accessible to all patients, empowering them with the knowledge needed to make informed decisions about their treatment options. The company’s core values include integrity, compassion, and a relentless pursuit of scientific advancement.

Through its commitment to quality, innovation, and patient care, NeoGenomics continues to be at the forefront of cancer diagnostics, striving to transform the landscape of cancer treatment and improve the lives of patients worldwide.